Healius logo

Healius(ASX) HLS

Market CapA$283.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1998)+26%
5 Year-88%
1 Year-52%
1 Month-9%
A$0.39
-1.28%
-0.00Today
Healius last closing stock price
MetricPriceDate
Last closeAUD 0.392026-10-12
Healius stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.7%AUD 0.412026-10-05
1 month-9.3%AUD 0.432026-09-11
3 month-2.5%AUD 0.402026-07-14
Year to date-56.91%AUD 0.912025-12-31
1 year-51.55%AUD 0.812025-10-10
3 year-75.89%AUD 1.622023-10-13
5 year-88.21%AUD 3.312021-10-13
Since inception+25.83%AUD 0.311998-07-03

Healius Financials at a Glance

Market Cap

A$283.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$2.72B

Net Income (TTM)

-A$566.80M

EPS (TTM)

-A$0.57

P/E Ratio

-0.68

Dividend

A$0.00

Beta (Volatility)

0.04 (Low)

Price

A$0.39

Volume

10,787,465

Open

A$0.39

Previous Close

A$0.39

Daily Range

A$0.37 - A$0.39

52-Week Range

A$0.30 - A$1.07

Estimated Earnings Date

Feb 24, 2027

HLS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Healius

Healius Limited is an Australian company focused on providing specialized diagnostic services to consumers and healthcare practitioners. The firm operates through four main segments: Pathology, Medical Imaging, Day Hospitals, and other services, boasting a comprehensive network across Australia.

Products and Services
  • Comprehensive diagnostic imaging services
  • Private medical laboratory analysis and pathology services
  • Specialized surgical procedures including IVF and cosmetic surgeries
Growth Outlook
  • Expansion of pathology facilities to 2,105 locations enhances service accessibility
  • Increased demand for diagnostic services supports revenue growth potential
  • Strategic investments in technology aim to improve operational efficiency
Financial Highlights
  • Recent quarterly revenue of AUD 685.1 million reflects stable performance
  • Trailing twelve months (TTM) gross profit margin stands at 18.5%
  • Operating cash flow of AUD 117.9 million indicates strong cash generation
Healius Limited has established itself as a key player in the healthcare sector, particularly in diagnostics and surgical services. The company's diverse offerings and extensive network position it well to capitalize on the growing demand for healthcare services in Australia. Recent financial performance shows resilience, with a solid revenue base and effective cash flow management. The focus on expanding facilities and enhancing technology indicates a commitment to long-term growth and operational excellence.
AI Generated • Sep 30, 2026

Industry

Healthcare Providers and Services

Employees

8,000

CEO

Paul Anderson

Headquarters

Sydney, NSW 2000, AU

HLS Financials

Key Financial Metrics (TTM)

Gross Margin

18.50%

Operating Margin

2.20%

Net Income Margin

-30.27%

Return on Equity

-114.08%

Return on Capital

2.58%

Return on Assets

-29.32%

Earnings Yield

-1.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$283.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

726.18M

Volume

10.79M

Avg. Volume

4.81M

Financials (TTM)

Gross Profit

A$652.60M

Operating Income

A$30.40M

EBITDA

A$369.00M

Operating Cash Flow

A$485.20M

Capital Expenditure

-A$97.30M

Free Cash Flow

A$387.90M

Cash & ST Invst.

A$67.20M

Total Debt

A$998.70M

Healius Performance Analysis

Healius annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 1,706,900,000-25.4%
20242024-06-30AUD 1,271,800,000-25.5%
20252025-06-30AUD 1,344,200,0005.7%
20262026-06-30AUD 1,373,200,0002.2%
Healius sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-26.2%
Q42025-06-303.0%
Q22025-12-310.9%
Q42026-06-30-0.4%
Healius annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD -0.61N/A
20242024-06-30AUD -0.9860.9%
20252025-06-30AUD -0.72-25.9%
20262026-06-30AUD -0.57-21.1%
Healius sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-308.7%
Q42025-06-30-1158.9%
Q22025-12-3194.1%
Q42026-06-30-1164.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$685.10M

-23.6%

Gross Profit

A$136.50M

-50.8%

Gross Margin

19.92%

N/A

Market Cap

A$283.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$47.20K

N/A

Employees

6,000

N/A

Net Income

-A$385.20M

-3752.0%

EBITDA

A$22.30M

-78.1%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$67.20M

+11.8%

Total Debt

A$998.70M

-37.5%

Accounts Receivable

A$158.30M

-15.6%

Inventory

A$35.00M

+9.7%

Long Term Debt

A$818.70M

-38.3%

Short Term Debt

A$180.00M

-33.7%

Return on Assets

-29.32%

N/A

Return on Invested Capital

3.01%

N/A

Free Cash Flow

A$91.70M

-24.1%

Operating Cash Flow

A$117.90M

-19.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MVF.AXMonash IVF Group Limited
A$0.75+0.67%
CTE.AXCryosite Limited
A$1.21+0.00%
BDX.AXBCAL Diagnostics Limited
A$0.09-1.10%
ACL.AXAustralian Clinical Labs Limited
A$2.86-1.72%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.67-0.89%
INTCIntel
$101.35-3.20%
NOKNokia
$9.90-4.44%
NVDANvidia
$226.32-1.29%

Questions About HLS

What is the current price of Healius?

Healius is trading at A$0.39 per share.

What is the 52-week range for Healius?

Over the past 52 weeks, Healius has traded between A$0.30 and A$1.07.

How much debt does Healius have?

As of the most recent reporting period, Healius reported total debt of A$996.40M.

How much cash does Healius have on hand?

Healius reported A$67.20M in cash and cash equivalents in its most recent financial results.

What is Healius’s dividend yield?

Healius does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.